(160) The Western Pennsylvania Hospital- Cancer Institute — Pittsburgh, Pennsylvania

(160) The Western Pennsylvania Hospital- Cancer Institute is a clinical research site located in Pittsburgh, Pennsylvania, United States 15224-1791.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

(160) The Western Pennsylvania Hospital- Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia, Acute Myelogenous Leukemia.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for (160) The Western Pennsylvania Hospital- Cancer Institute?

(160) The Western Pennsylvania Hospital- Cancer Institute has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has (160) The Western Pennsylvania Hospital- Cancer Institute conducted?

(160) The Western Pennsylvania Hospital- Cancer Institute has 1 clinical trials on record. Their work covers Acute Myeloid Leukemia, Acute Myelogenous Leukemia.

Is (160) The Western Pennsylvania Hospital- Cancer Institute accredited by Crixeo Health?

(160) The Western Pennsylvania Hospital- Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about (160) The Western Pennsylvania Hospital- Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.